REGISTER

Zero To Hide

APPROVED BY HEATON

  • Instant Withdrawals
  • VIP Transfer
  • Instant Rakeback
  • Weekly Cashback up to 35%

18+ · Gamble responsibly · T&Cs apply · help & info

EP Genesis vs Daystar — CS2 Match BO3 at Group B

FINISHED Group B ·BO3 ·
EP Genesis
CZ
🏆 Winner
2 : 1
Daystar
US
📺 Watch:

Match summary: EP Genesis vs Daystar

EP Genesis defeated Daystar 2-1 (Anubis 0-0, Mirage 0-0, Vertigo 0-0) in this BO3 Counter-Strike 2 match at Group B on November 4, 2024.

Map Results (3 maps)

MAP 1 Anubis
FINISHED
EP Genesis 🏆 0
Daystar 0
MAP 2 Mirage
FINISHED
EP Genesis 0
Daystar 🏆 0
MAP 3 Vertigo
FINISHED
EP Genesis 🏆 0
Daystar 0

Head-to-Head

1 EP Genesis
vs
0 Daystar
Group B
EP.G 2 : 1 DAY
BO3

Frequently Asked Questions

What is the score of EP Genesis vs Daystar?

The final score of EP Genesis vs Daystar was 2-1.

What format is EP Genesis vs Daystar?

BO3 (best of 3 maps). Part of Group B.

Where can I watch EP Genesis vs Daystar live?

Follow real-time scores and player statistics on this page. The match is also streamed on tournament broadcast channels.

What are the head-to-head stats for EP Genesis vs Daystar?

In recent head-to-head matchups, EP Genesis has won 1 and Daystar has won 0 out of 1 matches. View the full head-to-head breakdown on this page.

Match Recap: EP Genesis vs Daystar

EP Genesis defeated Daystar with a score of 2-1 in this BO3 Counter-Strike 2 match at United21 — Group B on November 4, 2024. The series was played across Anubis, Mirage, Vertigo.

In the head-to-head between these two sides, EP Genesis has taken 1 of their last 1 meetings while Daystar has claimed 0.

This page carries the EP Genesis vs Daystar BO3 matchup with basic scoreline info, tournament context and affiliate-partner odds from our reviewed sportsbook partners. Round-by-round live breakdowns and per-player kill/death streams live on canonical archives (HLTV.org, bo3.gg) — we do not duplicate that data feed. Editorial coverage of individual matches lives on /predictions/ when our editors write a preview.